News |

Shore Capital acts as Nomad and Sole Broker for £6.1m placing for FireAngel

FireAngel (AIM: FA.), one of Europe’s leading developers and suppliers of home safety products, announced a proposed open offer to […]

 

UK Budget must borrow to spend but not increase taxes

Howard Shore, Founder, Shore Capital Group and Puma Brandenburg To spend, or not to spend, that is not the question […]

 

News |

Shore Capital is Financial Adviser and Sole Bookrunner on the IPO of Nippon Active Value Fund plc

  First Investment Company IPO of the Decade on the London Stock Exchange            Nippon Active […]

 

News |

Shore Capital acts as Nomad and Sole Bookrunner for US$11.6m (£9.0m) placing for Touchstone Exploration

    Shore Capital is pleased to have acted as Nomad and Sole Bookrunner for Touchstone Exploration Inc. (“Touchstone”) on […]

 

News |

Shore Capital acts as Nomad, Sole Bookrunner and Sole Broker on £5m placing for Sosandar plc

Shore Capital is pleased to have acted as Nomad, Sole Bookrunner and Sole Broker for Sosandar plc (“Sosandar”) on a […]

 

News |

Shore Capital acts as Sole Bookrunner on £21.68m Accelerated Bookbuild in ScS

  Shore Capital is pleased to have acted for Parlour Product Holdings on its £21.68m sell-down in ScS Group Plc […]

 

News |

Clive Black talks sustainability in supply chains

Shore Capital’s Head of Research Clive Black helped the Company Shop to launch their annual Corporate Surplus Responsibility report at […]

 

Howard Shore forecasts business risks for 2020

Appearing on Bloomberg Surveillance on 12 December 2019, Howard Shore discussed the global business outlook going into 2020. He said: […]

 

If Boris wins a majority, prepare for the British economy to boom

Howard Shore, Founder, Shore Capital Group and Puma Brandenburg    Analysts trying to predict the UK’s economic outlook for 2020 […]

 

News |

Shore Capital appointed as Joint Broker to Cpl Resources

Shore Capital is delighted to have been appointed as Joint Broker to Cpl Resources PLC (“Cpl”), Ireland’s leading workforce solutions […]

 

News |

Shore Capital appointed as Nomad and Broker to Mpac Group

    Shore Capital is delighted to have been appointed as Nomad and Broker to Mpac Group plc (“Mpac”). Mpac […]

 

News |

Shore Capital acts as Sole Bookrunner on £13.75m Accelerated Bookbuild in ScS

  Shore Capital is pleased to have acted as Sole Bookrunner for Parlour Product Holdings on its £13.75m sell-down in […]

 

News |

Shore Capital acts as Broker and Sole Bookrunner on US$11.4m fundraise for Bahamas Petroleum

Bahamas Petroleum Company Plc (Bahamas Petroleum), the oil and gas exploration company with a significant prospective resource in licences in […]

 

SCGL Director/PDMR Shareholding – October 2019

  Shore Capital was notified today that Elizabeth van Messel, the wife of Michael van Messel, a Senior Executive of […]

 

SCGL – Result of General Meeting – Cancellation of admission to trading on AIM

  Shore Capital Group Limited (“Shore Capital,” the “Group” or the “Company”) Result of General Meeting – Cancellation of admission […]

 

News |

Shore Capital appointed as Nominated Adviser and Joint Broker to Epwin Group Plc

    Shore Capital is delighted to have been appointed as Nominated Adviser and Joint Broker to Epwin Group Plc […]

 

SCGL Director/PDMR Shareholding – September 2019

  Shore Capital was notified yesterday that Elizabeth van Messel, the wife of Michael van Messel, a Senior Executive of […]

 

Shore Capital announces its interim results for the six months ended 30 June 2019

  Shore Capital, the independent investment group specialising in capital markets, asset management and principal finance, today announces its interim […]

 

Proposed cancellation of admission of ordinary shares to trading on AIM and Notice of General Meeting

  Shore Capital, the independent investment group specialising in capital markets, asset management and principal finance, today announces its intention […]

 

News |

Shore Capital acts as Financial Adviser, Nomad and Joint Broker on Amryt Pharma’s acquisition of Aegerion Pharmaceuticals and its $60m fundraise

  Shore Capital is pleased to have acted as Financial Adviser, Nominated Adviser and Joint Broker on Amryt Pharma’s $153m […]

 

Our website uses necessary cookies in order for it to run. We would also like to use optional analytics cookies to improve the site, by collecting and reporting information on how you use it. These cookies do not directly identify the user and won’t set optional cookies unless they are accepted. For more information on how our site cookies work, please see our Privacy Policy.